Exchange: NASDAQ·Updated 05:53 AM EDT
GELS logo

GELS Gelteq Ltd.

$0.454
$0.0236
(5.48%)
Pre-Market
Prev Close $0.4304
Mkt Cap$4.78M
Vol2,360.00

About GELS

Gelteq Ltd. operates as a biotechnology company. It focuses on the development and commercialization of white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products. The firm also offers edible gels. The company was founded by Nathan J. Givoni and Simon H. Szewach on October 15, 2018 and is headquartered in Melbourne, Australia.
41

Bearish Sentiment

How do you feel about GELS?

BullishBellee
$GELS Proprietary gel-based drug-delivery platform for human plus veterinary applications.[]~

Advertisement|Remove ads.